Abstract
References
Articles referenced by this article (102)
Oral delivery of anticancer drugs: challenges and opportunities.
J Control Release, (1):15-40 2013
MED: 23648832
Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
Adv Drug Deliv Rev, (6):880-890 2012
MED: 23220325
Nanocarrier systems for oral drug delivery: do we really need them?
Eur J Pharm Sci, (2):272-277 2013
MED: 23537503
Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection.
J Med Virol, (5):886-894 2013
MED: 24122866
Phospholipids and lipid-based formulations in oral drug delivery.
Pharm Res, (8):1469-1486 2010
MED: 20411409
Title not supplied
The immunological adjuvant activity of gypenosides liposome against Newcastle disease vaccine.
Int J Biol Macromol, 116-121 2013
MED: 23732326
Enhanced oral bioavailability and tissue distribution of a new potential anticancer agent, Flammulina velutipes sterols, through liposomal encapsulation.
J Agric Food Chem, (25):5961-5971 2013
MED: 23721187
Effect of liposomes on the absorption of water-soluble active pharmaceutical ingredients via oral administration.
Curr Pharm Des, (37):6647-6654 2013
MED: 23621538
Show 10 more references (10 of 102)
Citations & impact
Impact metrics
Citations of article over time
Article citations
Design of Auto-Adaptive Drug Delivery System for Effective Delivery of Peptide Drugs to Overcoming Mucus and Epithelial Barriers.
AAPS J, 26(5):102, 12 Sep 2024
Cited by: 0 articles | PMID: 39266802
Carrier Systems for Advanced Drug Delivery: Improving Drug Solubility/Bioavailability and Administration Routes.
Pharmaceutics, 16(7):852, 25 Jun 2024
Cited by: 1 article | PMID: 39065549 | PMCID: PMC11279846
Review Free full text in Europe PMC
PEGose Block Poly(lactic acid) Nanoparticles for Cargo Delivery.
Macromolecules, 57(13):6013-6023, 14 Jun 2024
Cited by: 0 articles | PMID: 39005948
2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.
Int J Nanomedicine, 19:5273-5295, 06 Jun 2024
Cited by: 1 article | PMID: 38859952
Oral Delivery of the Vancomycin Derivative FU002 by a Surface-Modified Liposomal Nanocarrier.
Adv Healthc Mater, 13(14):e2303654, 01 Mar 2024
Cited by: 3 articles | PMID: 38387090 | PMCID: PMC11469192
Go to all (67) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging.
Drug Dev Ind Pharm, 44(4):608-614, 30 Nov 2017
Cited by: 10 articles | PMID: 29166794
Potential of Liposomes for Enhancement of Oral Drug Absorption.
Curr Drug Deliv, 14(2):289-303, 01 Jan 2017
Cited by: 52 articles | PMID: 26768542
Review
Characteristics and behaviour of liposomes when incubated with natural bile salt extract: implications for their use as oral drug delivery systems.
Soft Matter, 10(35):6677-6685, 01 Sep 2014
Cited by: 2 articles | PMID: 25060405
Preparation, characterization, in vitro and in vivo studies of liposomal berberine using novel natural Fiber Interlaced Liposomal technology.
Eur J Pharm Biopharm, 203:114431, 31 Jul 2024
Cited by: 0 articles | PMID: 39094668
Funding
Funders who supported this work.
Crohn's & Colitis Foundation (1)
Grant ID: 348137